Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 4,073 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Depression
Interventions: iTBS Device/Motor Threshold Coil, iTBS Device/Treatment Coil; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 13 Years to 17 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Ductal Breast Carcinoma in Situ, Breast Cancer, Stage I, Breast Cancer, Stage II, Breast Cancer, Stage III
Interventions: omega-3 fatty acid, placebo, Questionnaire administration; Dietary Supplement · Other · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Distracted Driving
Interventions: Intervention Bluetooth, Intervention non-Bluetooth, Control Bluetooth, Control non-Bluetooth; Other
Lead sponsor: Minnesota HealthSolutions; Industry
Eligibility: 16 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hormone Receptor Positive Breast Cancer
Interventions: Everolimus, Letrozole, Exemestane, Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study), Standard of care to treat stomatitis (Stomatitis sub-study); Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 15
States / cities: Birmingham, Alabama • Gilbert, Arizona • Loma Linda, California + 12 more

Conditions: Pregnancy Related, Weight Gain, Maternal
Interventions: SMART Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy, Subjective Cognitive Decline (SCD), Sedentary Behavior, Social Isolation in Older Adults
Interventions: Self-monitoring; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 60 Years and older
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Neck Pain
Interventions: Chiropractic + Supervised Rehabilitative Exercise, Supervised Rehabilitative Exercise, Self-care education; Procedure · Behavioral
Lead sponsor: Northwestern Health Sciences University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Bloomington, Minnesota

Conditions: Anorexia Nervosa, Avoidant/Restrictive Food Intake Disorder, Anxiety
Interventions: Weighted blanket; Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 89 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Depressive Disorder, Major
Interventions: Prism Training; Device
Lead sponsor: GrayMatters Health Ltd.; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Providence, Rhode Island • Houston, Texas

Conditions: Systemic Lupus Erythematosus
Interventions: CALLS; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Type 1 Diabetes Mellitus, Older Adults, Hypoglycemia
Interventions: eCGM (enhanced CGM); Other
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 65 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Renal Cell Carcinoma
Interventions: everolimus and bevacizumab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 3 more

Conditions: Cocaine Use Disorder
Interventions: Lorcaserin, Cocaine Intravenous (IV), Placebo comparator; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 59 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Mild Cognitive Impairment
Interventions: SAMSTAR, RAVLT; Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 55 Years to 84 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Durham, North Carolina

Conditions: Depression, Anxiety
Interventions: Woebot for Adolescents (W-GenZD) Mobile Application, CBT-Lite Teletherapy Group; Device · Behavioral
Lead sponsor: Woebot Health; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Type 1 Diabetes
Interventions: Type 1 Doing Well (T1DW) Program, Diabetes-Related Information and Resources Program; Behavioral · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 10 Years to 99 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Childhood Cancer Survivors
Interventions: Children's Oncology Group Heart Health Link, Monthly weights, Fasting, Calls, Participant Questionnaires, Dried blood spot; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 4
States / cities: New York, New York • Memphis, Tennessee • Seattle, Washington

Conditions: Influenza, Vaccine Hesitancy
Interventions: Text messaging; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 6 Months and older
Enrollment: 228,831 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetes Mellitus, Type 2
Interventions: Semaglutide; Drug
Lead sponsor: Emory University; Other
Eligibility: 65 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Overactive Bladder
Interventions: Macrobid® Capsules 100 mg, Standard Medical Care (SMC); Drug · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Psychosis, Substance Use, Substance Use Disorders, Family, Tobacco Use, Nicotine Use Disorder, Cigarette Smoking, Cannabis, Marijuana, Alcohol Use Disorder, Alcohol, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Mental Disorder
Interventions: CRAFT-FT; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Relapsing-Remitting Multiple Sclerosis
Interventions: Step Tracking, Water Tracking; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 30 Years to 59 Years
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Inflammatory Bowel Disease
Interventions: MBC-IBD Intervention, Enhanced Treatment as Usual (E-TAU); Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Decatur, Georgia • Ann Arbor, Michigan • Portland, Oregon + 1 more

Conditions: Exercise, Transplantation
Interventions: Exercise program; Other
Lead sponsor: Phoenix Children's Hospital; Other
Eligibility: 4 Years to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

iTBS for Adolescent Depression: An Open Label Study Evaluating Safety and Efficacy of Treatment

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Preventing Distracted Driving Phase II

Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer

A Pilot Study to Evaluate an Intervention for Gestational Weight Gain

Increasing Physical Activity Through Social Support and Stress Resilience

Manipulation, Exercise, and Self-Care for Neck Pain

Assessing the Impact of Weighted Blankets on Anxiety Among Inpatients With Anorexia Nervosa: a Study Protocol

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Care Coordination Approaches to Learning Lupus Self-management

Technological Advances in Glucose Management in Older Adults

Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)

Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive Impairment

Feasibility and Acceptability of W-GenZD vs CBT-light Teletherapy for Adolescents Seeking Mental Health Services

EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Precision Vaccine Promotion in Underserved Populations

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms

Families With Substance Use and Psychosis: A Pilot Study

Behavior and Activity Monitoring in MS

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

Benefits of Exercise Program in Pediatric HSCT